J.A. van Dongen

1.1k total citations
37 papers, 859 citations indexed

About

J.A. van Dongen is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, J.A. van Dongen has authored 37 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cancer Research, 14 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in J.A. van Dongen's work include Breast Cancer Treatment Studies (21 papers), Breast Lesions and Carcinomas (5 papers) and BRCA gene mutations in cancer (4 papers). J.A. van Dongen is often cited by papers focused on Breast Cancer Treatment Studies (21 papers), Breast Lesions and Carcinomas (5 papers) and BRCA gene mutations in cancer (4 papers). J.A. van Dongen collaborates with scholars based in Netherlands, Belgium and Malaysia. J.A. van Dongen's co-authors include IS Fentiman, Flora E. van Leeuwen, Liesbeth Bergman, Emiel J. Rutgers, J.L. Peterse, Ronald B. Keus, B.B.R. Kroon, Hans Peterse, Abram Recht and Frits S.A.M. van Dam and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

J.A. van Dongen

37 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.A. van Dongen Netherlands 16 429 409 273 149 146 37 859
J. Bonnema Netherlands 14 749 1.7× 590 1.4× 461 1.7× 103 0.7× 454 3.1× 19 1.2k
Lorraine A. A. Champion United States 8 695 1.6× 527 1.3× 303 1.1× 57 0.4× 177 1.2× 9 1.2k
I. Monypenny United Kingdom 13 309 0.7× 315 0.8× 208 0.8× 41 0.3× 117 0.8× 30 579
Kathie‐Ann Joseph United States 17 388 0.9× 363 0.9× 381 1.4× 134 0.9× 194 1.3× 60 1.0k
Alan C. Winfield United States 14 262 0.6× 272 0.7× 322 1.2× 44 0.3× 149 1.0× 32 915
Jessica Goldberg United States 14 514 1.2× 298 0.7× 452 1.7× 120 0.8× 291 2.0× 38 918
P.A. Lawton United Kingdom 12 817 1.9× 562 1.4× 321 1.2× 66 0.4× 313 2.1× 19 1.4k
Janine Bell United Kingdom 10 158 0.4× 423 1.0× 118 0.4× 113 0.8× 182 1.2× 11 1.0k
Leo J. Mahoney Canada 11 925 2.2× 454 1.1× 554 2.0× 66 0.4× 298 2.0× 23 1.2k
Alfonso Frigerio Italy 14 254 0.6× 432 1.1× 188 0.7× 39 0.3× 92 0.6× 42 718

Countries citing papers authored by J.A. van Dongen

Since Specialization
Citations

This map shows the geographic impact of J.A. van Dongen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. van Dongen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. van Dongen more than expected).

Fields of papers citing papers by J.A. van Dongen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. van Dongen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. van Dongen. The network helps show where J.A. van Dongen may publish in the future.

Co-authorship network of co-authors of J.A. van Dongen

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. van Dongen. A scholar is included among the top collaborators of J.A. van Dongen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. van Dongen. J.A. van Dongen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bijker, Nina, Emiel J. Rutgers, J.L. Peterse, et al.. (2001). Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS. European Journal of Surgical Oncology. 27(2). 135–140. 35 indexed citations
2.
Julien, Jean‐Pierre, Nina Bijker, Ian S. Fentiman, et al.. (2001). Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. Cancer/Radiothérapie. 5(2). 193–194. 18 indexed citations
3.
Kapteijn, B.A.E., Omgo E. Nieweg, Jason L. Petersen, et al.. (1998). Identification and biopsy of the sentinel lymph node in breast cancer. European Journal of Surgical Oncology. 24(5). 427–430. 71 indexed citations
4.
Koning, Harry J. de, J.W.W. Coebergh, & J.A. van Dongen. (1996). Current controversies in cancer : Is mass screening for breast cancer cost-effective ? Pro, contra and arbiter. European Journal of Cancer. 32(11). 1835–1839. 1 indexed citations
5.
Tienhoven, Geertjan van, Adri C. Voogd, & J.A. van Dongen. (1996). PP-3-8 Prognosis after salvage treatment for local-regional recurrence of mastectomy or breast conservation in eortic trial 10801. European Journal of Cancer. 32. 21–21. 1 indexed citations
6.
Aaronson, N.K., Martin J. Muller, Astrid C. van der Schot, et al.. (1996). Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials.. Journal of Clinical Oncology. 14(3). 984–996. 148 indexed citations
7.
Nieweg, OE, B.A.E. Kapteijn, J. L. Peterse, et al.. (1996). [Identification of the sentinel node in patients with breast carcinoma].. PubMed. 140(45). 2235–9. 17 indexed citations
8.
Koning, Harry J. de, et al.. (1996). Is mass screening for breast cancer cost-effective?. European Journal of Cancer. 32(11). 1835–1839. 7 indexed citations
9.
Janse, Arieke J., Frits van Coevorden, Hans Peterse, Ronald B. Keus, & J.A. van Dongen. (1995). Lymphedema-induced lymphangiosarcoma. European Journal of Surgical Oncology. 21(2). 155–158. 27 indexed citations
10.
Vrouenraets, B. C., et al.. (1994). Long-term neuropathy after regional isolated perfusion with melphalan for melanoma of the limbs.. PubMed. 20(6). 681–5. 19 indexed citations
11.
Borger, Jacques, Geertjan van Tienhoven, Augustinus A. M. Hart, et al.. (1992). Primary radiotherapy of breast cancer: Treatment results in locally advanced breast cancer and in operable patients selected by positive axillary apex biopsy. Radiotherapy and Oncology. 25(1). 1–11. 26 indexed citations
12.
Bartelink, Harry, et al.. (1992). Locoregional recurrence after mastectomy or breast conserving therapy; analysis of clinical prognostic factors and results of salvage therapy in a randomized EORTC trial. International Journal of Radiation Oncology*Biology*Physics. 24. 219–220. 1 indexed citations
13.
Bergman, Liesbeth, et al.. (1991). Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer. Breast Cancer Research and Treatment. 18(3). 189–198. 73 indexed citations
14.
Bergman, Liesbeth, et al.. (1991). The effect of age on treatment choice and survival in elderly breast cancer patients. Cancer. 67(9). 2227–2234. 92 indexed citations
15.
Kroon, B.B.R., et al.. (1990). Lymph node metastasis from melanoma with an unknown primary site. British journal of surgery. 77(6). 665–668. 26 indexed citations
16.
Dongen, J.A. van. (1989). Early Breast Cancer: A review. Acta Oncologica. 28(1). 123–134. 9 indexed citations
17.
Wildiers, J., K. Vantongelen, J.A. van Dongen, Nicole Rotmensz, & Richard Sylvester. (1988). Activities of the EORTC Breast Cancer Co-operative Group: an overview. European Journal of Cancer and Clinical Oncology. 24(1). 3–8. 5 indexed citations
18.
Schueren, Emmanuel van der & J.A. van Dongen. (1988). Management of early stage breast cancer—current status of treatment: Workshop report. European Journal of Cancer and Clinical Oncology. 24(1). 89–93. 4 indexed citations
19.
Dongen, J.A. van, et al.. (1965). De mulierum organis generationi inservientibus, 1672. 1 indexed citations
20.
Dongen, J.A. van, et al.. (1965). De mulierum organis generationi inservientibus, 1672 : facsimile. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026